Novel therapeutic targets in advanced gastric cancer : the insulin-like growth factor signal transduction pathway
Patients with advanced gastric cancer have limited therapeutic options to which response rates are low. Very few targeted therapies are available. There is an urgent need for novel targeted inhibitors for patients who are either ineligible for the existing targeted therapies or have developed resist...
Main Author: | Saisana, Marina |
---|---|
Published: |
University of Newcastle upon Tyne
2016
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.722332 |
Similar Items
-
Modulation of signal transduction pathways by dietary cancer chemopreventive agents
by: Squires, Matthew Simon
Published: (2000) -
FABP5-related signalling pathway used as therapeutic target for castration-resistance prostate cancer
by: Al-Jameel, W. H.
Published: (2017) -
Insulin-like growth factors and genetic susceptibility to breast cancer
by: Al-Zahrani, Ali Saeed
Published: (2005) -
Investigation of aberrant signal transduction in acute myeloid leukaemia
by: Grandage, V. L.
Published: (2007) -
Role of insulin-like growth factor-type 1 receptor (IGF-IR) signalling in tamoxifen-resistant breast cancer
by: Knowlden, Janice M.
Published: (2008)